| Size & multiples | |||
| Market Cap | $90.55B | Enterprise Value | $136.00B |
| P/E (TTM) | 14.41× | PEG (trailing) | 1.03× |
| P/S | 1.19× | P/FCF | 11.42× |
| EV/EBITDA | 8.68× | EV/EBIT | 11.26× |
| EV/Sales | 1.78× | EV/FCF | 17.16× |
| FCF Yield | 8.75% | Buyback Yield | 10.08% |
| Owner Earnings (TTM) | $6.79B | Owner Earnings Yield | 7.50% |
| Shareholder Yield | 10.84% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.07 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.37% |
| After-tax Cost of Debt | 3.89% | Synthetic credit rating | A |
| Cost of Debt · embedded (pre-tax) | 4.91% | Cost of Debt · marginal (synthetic) | 4.78% |
| WACC | 7.51% | ROIC | 22.67% |
| EVA Spread (ROIC−WACC) | 15.16% | EVA | $6.47B |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $28.33 · revenue TTM $76.39B · FCF TTM $7.93B
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on P/E
P/E 30th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 14.4x | 24.4x | 12.9x–38.8x | 30 ↓cheap |
| FCF Yield | 8.5% | -7.9% | -35.6%–1.4% | 93 ↑strong |
| Dividend Yield | 0.7% | 1.1% | 0.2%–2.4% | 38 ↓weak |
| Net Margin | 9.0% | -21.2% | -325.3%–7.2% | 79 ↑strong |
